一种用于克服非小细胞肺癌治疗中抗原异质性的多靶向 CAR-T 细胞平台
A Multi-Targeting Chimeric Antigen Receptor-T Cell Platform to Overcome Antigen Heterogeneity in the Treatment of Non-Small Cell Lung Cancer.
这些发现支持采用多靶点CAR-T 策略来应对NSCLC及可能其他实体瘤中的抗原异质性。
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Prognostic significance of tumor microenvironment assessed by machine learning algorithm in surgically resected non-small cell lung cancer.
Prognostic significance of tumor microenvironment assessed by machine learning algorithm in surgically resected non-small cell lung cancer.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
我们的方法表明,IME 因素与非小细胞肺癌患者的生存相关。
目前尚未建立评估非小细胞肺癌(NSCLC)免疫微环境(IME)的方法,IME因素的预后影响也尚不明确。
评估IME因素及其预后价值。方法与结果:我们在全切片影像(WSI)中使用机器学习算法评估CD8+TIL(肿瘤浸润淋巴细胞)密度、叉头框蛋白P3(Foxp3)阳性TIL密度及程序性死亡配体1(PD-L1)肿瘤比例评分(TPS)。根据TIL密度或TPS将患者二分,并比较临床结局。2014年9月至2015年9月,共纳入165例NSCLC患者。研究分别评估了上皮、间质及两者联合区域中的IME因素。上皮、间质及两者联合区域中CD8+ TIL密度较高组的无病生存期(DFS)均有所改善。此外,上皮中PD-L1 TPS较高组的DFS优于TPS较低组。多变量分析显示,上皮与间质联合区域的CD8+ TIL密度及上皮中的PD-L1 TPS均为独立预后因素(风险比[HR]=0.43;95%置信区间[CI]=0.26–0.72;p=0.001;HR=0.49;95% CI=0.30–0.81;p=0.005)。
本研究方法显示,IME因素与NSCLC患者生存相关。定量评估IME因素有助于识别复发高风险患者,这些患者可能适合接受辅助治疗。联合评估上皮和间质区域的CD8+ TIL密度可能比单独评估更有价值,因为它可在WSI上以简单、省时的方式分析TIL。
A methodology to assess the immune microenvironment (IME) of non-small cell lung cancer (NSCLC) has not been established, and the prognostic impact of IME factors is not yet clear. AIMS: This study aimed to assess the IME factors and evaluate their prognostic values. METHODS AND RESULTS: We assessed CD8 + tumor-infiltrating lymphocyte (TIL) density, forkhead box protein P3 + (Foxp3 + ) TIL density, and programmed death receptor ligand-1 (PD-L1) tumor proportion score (TPS) using a machine-learning algorithm in whole-slide imaging (WSI). We dichotomized patients according to TIL density or TPS and compared their clinical outcomes. Between September 2014 and September 2015, 165 patients with NSCLC were enrolled in the study. We assessed IME factors in the epithelium, stroma, and their combination. An improvement in disease-free survival (DFS) was observed in the high CD8 + TIL density group in the epithelium, stroma, and the combination of both. Moreover, the group with high PD-L1 TPS in the epithelium showed better DFS than that with low PD-L1 TPS. In the multivariate analysis, the CD8 + TIL density in the combination of epithelium and stroma and PD-L1 TPS in the epithelium were independent prognostic factors (hazard ratio [HR] = 0.43; 95% confidence interval [CI] = 0.26-0.72; p = .001, HR = 0.49; 95% CI = 0.30-0.81; p = .005, respectively).
Our approach demonstrated that the IME factors are related to survival in patients with NSCLC. The quantitative assessment of IME factors enables to discriminate patients with high risk of recurrence, who can be the candidates for adjuvant therapy. Assessing the CD8 + TIL density in the combination of epithelium and stroma might be more useful than their individual assessment because it is a simple and time-saving analysis of TILs in WSI.
MEMBER ACCOUNT
登录成功会直接打开下一页。